Interestingly, Tregs isolated from ovarian cancer tissues were more sensitive to TNFR2 antagonist-induced cell death (23), presumably attributable to the higher levels of TNFR2 expression on tumor-infiltrating Tregs (4). This evidence concerns the gene TNFRSF1B and ovarian cancer.